Novartis reaches $678 million settlement of U.S. fraud lawsuit

This post was originally published on this site

The U.S. Department of Justice announced the settlement late on Wednesday to resolve charges that Novartis violated the federal False Claims Act and an anti-kickback statute.

Add Comment